Cash & equivalents increased 111.7%
Cash & equivalents changed +111.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +111.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Inventory changed +31.6% from the comparable as-filed period.
Research & development changed +14.6% from the comparable as-filed period.
Gross profit changed +17.9% from the comparable as-filed period.
Operating income changed -16.0% from the comparable as-filed period.
Gross margin changed +124 basis points from the comparable as-filed period.
Revenue changed +9.3% from the comparable as-filed period.
Net income changed +1.0% from the comparable as-filed period.
Operating margin changed -56 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.